Gastric cancer is one of the most common cancers worldwilde. The five-year survival for stage IV gastric cancer is around 5-10% in Western countries. Advanced gastric cancer is sensitive to numerous agents, but there is no generally accepted standard regimen. Here we report on a case of advanced gastric cancer occurring in a 72-year-old man who underwent treatment with capecitabine plus oxaliplatin, achieving a complete response.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/030089161109700120 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!